Journal article
Angiotensin inhibition in renovascular disease: A population-based cohort study
Abstract
BACKGROUND: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers effectively reduce blood pressure in patients with renovascular disease (RVD); yet, randomized cardiovascular prevention trials of these drugs typically exclude individuals with this condition.
PATIENTS AND METHODS: We studied the association of renin-angiotensin system inhibition with prognosis in a population-based cohort comprising 3,570 patients with RVD …
Authors
Hackam DG; Duong-Hua ML; Mamdani M; Li P; Tobe SW; Spence JD; Garg AX
Journal
American Heart Journal, Vol. 156, No. 3, pp. 549–555
Publisher
Elsevier
Publication Date
9 2008
DOI
10.1016/j.ahj.2008.05.013
ISSN
0002-8703
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
Acute Kidney InjuryAgedAged, 80 and overAngiotensinsCardiovascular DiseasesCohort StudiesFemaleFollow-Up StudiesHeart FailureHormone AntagonistsHospitalizationHumansKidneyKidney DiseasesMaleMyocardial InfarctionProportional Hazards ModelsRenal DialysisRenin-Angiotensin SystemRisk AssessmentStrokeVascular Diseases